Rajesh Singh, Ph.D. 

Kumar S, Singh RK, Sharma R, Murthy RS, Bhardwaj TR. Design, Synthesis and Evaluation of Antimalarial Potential of Polyphosphazene Linked Combination Therapy of Primaquine and Dihydroartemisinin. Eur J Pharm Sci. 2014 Oct 10. pii: S0928-0987(14)00380-7. doi: 10.1016/j.ejps.2014.09.023. PMID: 25312346

Gupta P, Sharma PK, Mir H, Singh R, Singh N, Kloecker GH, Lillard JW Jr, Singh S. CCR9/CCL25 expression in non-small cell lung cancer correlates with aggressive disease and mediates key steps of metastasis. Oncotarget. 2014 Sep 25. PMID: 25296976

Corey GR, Good S, Jiang H, Moeck G, Wikler M, Green S, Manos P, Keech R, Singh R, Heller B, Bubnova N, O'Riordan W; for the SOLO II Investigators. Single-dose Oritavancin Compared to 7-10 days of Vancomycin in the Treatment of Gram-Positive Acute Bacterial Skin and Skin Structure Infections; the SOLO II Non-inferiority Study. Clin Infect Dis. 2014 Oct 6. pii: ciu778. PMID: 25294250

Loghavi S, Zuo Z, Ravandi F, Kantarjian HM, Bueso-Ramos C, Zhang L, Singh RR, Patel KP, Medeiros L, Stingo F, Routbort M, Cortes J, Luthra R, Khoury JD. Clinical features of De Novo acute myeloid leukemia with concurrent DNMT3A , FLT3 and NPM1 mutations. MID: 25281355 

Singh R, Gupta P, Kloecker GH, Singh S, Lillard Jr JW. Expression and clinical significance of CXCR5/CXCL13 in human non‑small cell lung carcinoma. Int J Oncol. 2014 Sep 30. doi: 10.3892/ijo.2014.2688. PMID: 25271023

Tomar D, Singh R. TRIM13 regulates ubiquitination and turnover of NEMO to suppress TNF induced NF-κB activation. Cell Signal. 2014 Aug 23;26(12):2606-2613. doi: 10.1016/j.cellsig.2014.08.008. PMID: 25152375


Click here to view additional publications.